Peringkat dalam Saham
#17840
Neovasc Inc. is a medical technology firm specializing in the design,... Neovasc Inc. is a medical technology firm specializing in the design, production, and global distribution of cardiovascular devices, particularly across European markets and beyond. Its primary offerings include the Tiara system, developed for the transcatheter treatment of mitral valve disease, and the Neovasc Reducer, used to address chronic, debilitating chest pain known as refractory angina. Established in 2000, the company, which maintains its headquarters in Richmond, Canada, was formerly named Medical Ventures Corp. before adopting its current identity, Neovasc Inc., in July 2008.
Harga Saham
$29.82
Terakhir disinkronkan: 2023-04-11
Kapitalisasi Pasar
$223.68M
Perubahan (1 tahun)
0.00%
Perdagangan Neovasc Inc. (NVCN)
Harga NVCN dengan kapitalisasi pasar B
Kapitalisasi pasar dari Neovasc Inc.(NVCN)
Kapitalisasi Pasar: $223.68M
Per September 2026, Neovasc Inc. memiliki kapitalisasi pasar sebesar $223.68M. Ini menjadikan Neovasc Inc. sebagai perusahaan 17840th paling bernilai di dunia menurut data kami. Kapitalisasi pasar adalah nilai total saham beredar dari perusahaan publik dan biasanya digunakan untuk mengukur seberapa besar nilai sebuah perusahaan.
Riwayat kapitalisasi pasar Neovasc Inc. dari 2001 hingga 2026
NVCN dibandingkan dengan 5 teratas stocks paling populer
| Harga NVCN |
|
Aset B |
Pasar B |
Hasil |
|
|
|
|
$5.424T
|
+2,424,906.63%
|
|
|
|
|
$4.776T
|
+2,135,027.86%
|
|
|
|
|
$4.052T
|
+1,811,320.46%
|
|
|
|
|
$3.691T
|
+1,650,030.99%
|
|
|
|
|
$2.744T
|
+1,226,752.87%
|
